Catalyzing Health Innovations in Mexico
About the Program
Village Capital and MetLife Foundation Mexico are launching an accelerator program for Mexican startups that are looking for innovation in the treatment and prevention of some of the most prevalent medical conditions in Mexico; obesity, diabetes and high blood pressure.
The prevalence of chronic conditions such as obesity, high blood pressure and diabetes in Mexico is still on the rise. According to the Food and Agriculture Organization of the United Nations, 24 million Mexicans suffer from obesity, making Mexico the sixth most affected country. Also, according to the Mexican Diabetes Federation, 10 million Mexican adults suffer from diabetes.
These conditions, if not prevented or left untreated, can lead to other serious consequences such as blindness, limb amputations, renal insufficiency o cardiac arrest. There is an urgent need for solutions that reduce costs and allow access to preventive treatment for all Mexican patients, no matter their income.
Entrepreneurs are solving these problems. Startups have the potential to create high quality, affordable solutions that promote a healthy lifestyle and improve access and follow-through of treatment.
Village Capital and MetLife Foundation Mexico will select 5 startups that are helping slow down this rising trend. Through a 3-day acceleration program in Mexico City entrepreneurs will receive mentoring from industry experts, training in the development of their business with Village Capital’s VIRAL methodology, and touch points in investors and allies networks they need to grow their business.
Also, every startup that applies to this program will have the opportunity to be part of Village Capital's global Abaca network, with over 1,000 investors and organizations that are supporting social entrepreneurs.
At the end of the program, two out of the five participating ventures will win a $100,000 MXN grant each.
Applications will be open until March 17th.
The startups invited to participate are those that focus on the prevention and/or treatment of obesity, diabetes and/or high blood pressure by:
• Helping to register, process or evaluate glucose levels, arterial pressure, weight, and other primary health indicators;
• Using or developing technology, devices or services to detect, diagnose and treat patient’s conditions, particularly in low income or marginalized communities;
• Developing foods or alternative nutrition sources or sugar substitutes that promote a healthy and preventive diet;
• Supporting the establishment and follow-through of healthy physical activity routines.
• The venture must have one full time employee, which may include the founding team.
• The venture must be constituted in Mexico, and cannot have received more than $1M in external funding. Confirmation documents will be required.